Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer

Journal of Clinical Oncology

Volumn 26, Issue 18, 2008, Pages 2984-2991

  Ng, Kimmie ^a   Meyerhardt, Jeffrey A ^a   Wu, Kana ^a   Feskanich, Diane ^a   Hollis, Bruce W ^a   Giovannucci, Edward L ^a   Fuchs, Charles S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL; ADULT; AGED; BLOOD; COHORT ANALYSIS; COLORECTAL TUMOR; MIDDLE AGED; MORTALITY; TUMOR RECURRENCE;

ADULT; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; VITAMIN D;

EID: 46449125088     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.1027     Document Type: Article

References (44)

1. Meggouh F, Lointier P, Saez S: Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res 51:1227-1233, 1991
2. Vandewalle B, Adenis A, Hornez L, et al: 1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett 86:67-73, 1994
3. Zehnder D, Bland R, Williams MC, et al: Extrarenal expression of 25-hydroxyvitamin d(3)-1 alphahydroxylase. J Clin Endocrinol Metab 86:888-894, 2001
4. Vandewalle B, Wattez N, Lefebvre J: Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: Possible implication of intracellular calcium. Cancer Lett 97:99-106, 1995
5. Díaz GD, Paraskeva C, Thomas MG, et al: Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res 60:2304-2312, 2000
6. Scaglione-Sewell BA, Bissonnette M, Skarosi S, et al: A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: Roles of cyclin E, p21Waf1, and p27Kip1. Endocrinology 141:3931-3939, 2000
7. Iseki K, Tatsuta M, Uehara H, et al: Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J Cancer 81:730-733, 1999
8. Fernandez-Garcia NI, Palmer HG, Garcia M, et al: 1alpha,25- Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 24:6533-6544, 2005
9. Lamprecht SA, Lipkin M: Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci 952:73-87, 2001
10. Evans SR, Shchepotin EI, Young H, et al: 1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine- induced colon carcinogenesis model. Int J Oncol 16:1249-1254, 2000
11. Garland CF, Comstock GW, Garland FC, et al: Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 2:1176-1178, 1989
12. Braun MM, Helzlsouer KJ, Hollis BW, et al: Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 142:608-611, 1995
13. Tangrea J, Helzlsouer K, Pietinen P, et al: Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8:615-625, 1997
14. Feskanich D, Ma J, Fuchs CS, et al: Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13: 1502-1508, 2004
15. Wactawski-Wende J, Kotchen JM, Anderson GL, et al: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354:684-696, 2006
16. Wu K, Feskanich D, Fuchs CS, et al: A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99:1120-1129, 2007
17. Gorham ED, Garland CF, Garland FC, et al: Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med 32:210-216, 2007
18. Lappe JM, Travers-Gustafson D, Davies KM, et al: Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 85:1586-1591, 2007
19. Robsahm TE, Tretli S, Dahlback A, et al: Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 15:149-158, 2004
20. Moan J, Porojnicu AC, Robsahm TE, et al: Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B 78:189-193, 2005
21. Belanger CF, Hennekens CH, Rosner B, et al: The nurses' health study. Am J Nurs 78:1039-1040, 1978
22. Colditz GA, Manson JE, Hankinson SE: The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 6:49-62, 1997
23. Giovannucci E, Colditz GA, Stampfer MJ, et al: A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 86:192-199, 1994
24. Giovannucci E, Liu Y, Rimm EB, et al: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-459, 2006
25. Sathiakumar N, Delzell E, Abdalla O: Using the National Death Index to obtain underlying cause of death codes. J Occup Environ Med 40:808-813, 1998
26. Stampfer MJ, Willett WC, Speizer FE, et al: Test of the National Death Index. Am J Epidemiol 119:837-839, 1984
27. Hollis BW: Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 282:174-186, 1997
28. Platz EA, Leitzmann MF, Hollis BW, et al: Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15:255-265, 2004
29. Meyerhardt JA, Giovannucci EL, Holmes MD, et al: Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24:3527-3534, 2006
30. Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial. BMJ 326:469, 2003
31. Zhou W, Heist RS, Liu G, et al: Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25:479-485, 2007
32. Deeb KK, Trump DL, Johnson CS: Vitamin D signaling pathways in cancer: Potential for anticancer therapeutics. Nat Rev Cancer 7:684-700, 2007
33. Giuliano AR, Franceschi RT, Wood RJ: Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: Effect of cellular differentiation. Arch Biochem Biophys 285:261-269, 1991
34. Zhao X, Feldman D: Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 132:1808-1814, 1993
35. Shabahang M, Buras RR, Davoodi F, et al: Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res 54:4057-4064, 1994
36. Eisman JA, Barkla DH, Tutton PJ: Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 47:21-25, 1987
37. Müller K, Odum N, Bendtzen K: 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 35:177-182, 1993
38. Gurlek A, Pittelkow MR, Kumar R: Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): Implications in cell growth and differentiation. Endocr Rev 23:763-786, 2002
39. Aldhahi W, Hamdy O: Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 3:293-298, 2003
40. Piché ME, Lemieux S, Weisnagel SJ, et al: Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 96:92-97, 2005
41. Rimm EB, Stampfer MJ, Colditz GA, et al: Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466-473, 1990
42. Wolf AM, Hunter DJ, Colditz GA, et al: Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 23:991-999, 1994
43. Rothman KJ, Greenland S: Precision and validity in epidemiologic studies, in Rothman KJ, Greenland S (eds): Modern Epidemiology (ed 3). Philadelphia, PA, Lippincott Williams & Wilkins, 1998, pp 115-134
44. VanEenwyk J, Campo JS, Ossiander EM: Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum. Cancer 95:39-46, 2002